ArticleJAMA oncology2018
PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions.
Vered Stearns et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it